Aspire Biopharma Holdings (ASBP) EBT Growth (1y) (2025 - 2026)

Aspire Biopharma Holdings (ASBP) EBT Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -0.10%
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,140.26%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 71.54%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -8.15%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 88.57%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Aspire Biopharma Holdings 1.09 Mn -733,865.14 5,750.00 79.78%

Historic Data

Download Data
DateValue
Mar 31, 2026 79.78%
Dec 31, 2025 -1,257.00%
Sep 30, 2025 -1,119.74%